Physician
NPI deactivated
ST. Joseph Health Services of Ri
ST. Joseph Health Services of Ri was paid $5.84M by Medicaid between Jan 2018 and Jan 2020, across 115 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 24% of everything it billed.
33Billing provider infoST. JOSEPH HEALTH SERVICES OF RI
NORTH PROVIDENCE, RI 02904
NORTH PROVIDENCE, RI 02904
33aNPI1992840862assigned 02/20/2007
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$5.84M
24GClaims74,516
24DCodes billed115
24AFirst – last monthJan 2018 – Jan 2020
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Rhode Island
Rank by total paid#1 of 18
Median peer was paid$37K
This provider vs. median157×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,007 | $2.77M | |
| 2019 | 42,471 | $3.06M | |
| 2020 | 38 | $21K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 24% | 595 | 326 | $1.41M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 2,325 | 1,924 | $1.22M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 1,605 | 1,205 | $836K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.4% | 728 | 536 | $375K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.8% | 426 | 378 | $222K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.0% | 2,752 | 2,437 | $174K |
| 80061 | Lipid panel | 1.9% | 3,989 | 3,530 | $114K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.9% | 1,506 | 1,324 | $113K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.9% | 1,505 | 1,324 | $112K |
| 80050 | General health panel | 1.9% | 2,222 | 1,971 | $108K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.7% | 932 | 762 | $98K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 1,139 | 938 | $76K |
103 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 1,783 | $64K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,217 | $58K |
| 80053 | Comprehensive metabolic panel | <1% | 1,948 | $45K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,109 | $39K |
| 82607 | <1% | 1,112 | $36K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,862 | $35K |
| 80074 | <1% | 338 | $34K | |
| 87070 | <1% | 414 | $27K | |
| 87480 | <1% | 586 | $25K | |
| 87510 | <1% | 585 | $25K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,138 | $24K |
| 82728 | <1% | 699 | $20K | |
| 84439 | <1% | 1,052 | $20K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 197 | $19K |
| 81001 | <1% | 2,814 | $19K | |
| 84154 | <1% | 483 | $19K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 520 | $18K |
| 86803 | <1% | 615 | $18K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,140 | $17K |
| 87186 | <1% | 767 | $16K | |
| 85027 | <1% | 1,126 | $16K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,445 | $16K |
| 88142 | <1% | 362 | $15K | |
| 80076 | <1% | 851 | $15K | |
| 86706 | <1% | 661 | $15K | |
| 86618 | <1% | 409 | $15K | |
| 84466 | <1% | 522 | $14K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 136 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 260 | $13K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 79 | $11K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 176 | $11K |
| 87081 | <1% | 745 | $11K | |
| 96127 | <1% | 442 | $10K | |
| 82746 | <1% | 454 | $10K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 55 | $10K |
| 87340 | <1% | 468 | $10K | |
| 86141 | <1% | 358 | $10K | |
| 83540 | <1% | 715 | $10K | |
| 86038 | <1% | 380 | $10K | |
| 82043 | <1% | 672 | $8K | |
| 84460 | <1% | 674 | $8K | |
| 87660 | <1% | 585 | $7K | |
| 82550 | <1% | 497 | $7K | |
| 84450 | <1% | 609 | $7K | |
| 86592 | <1% | 712 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 106 | $6K |
| 85652 | <1% | 1,033 | $6K | |
| 82565 | <1% | 526 | $6K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 78 | $6K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 253 | $6K |
| 87077 | <1% | 363 | $6K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 174 | $5K |
| 84403 | <1% | 87 | $5K | |
| 83690 | <1% | 314 | $5K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 116 | $5K |
| 82150 | <1% | 317 | $4K | |
| 87205 | <1% | 382 | $4K | |
| 86431 | <1% | 287 | $3K | |
| 86696 | <1% | 82 | $3K | |
| 80051 | <1% | 232 | $3K | |
| 85610 | <1% | 371 | $3K | |
| 82947 | <1% | 355 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 16 | $3K |
| 84436 | <1% | 185 | $3K | |
| 84520 | <1% | 318 | $3K | |
| 83735 | <1% | 184 | $3K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 25 | $2K |
| 86695 | <1% | 82 | $2K | |
| 84550 | <1% | 243 | $2K | |
| 86665 | <1% | 62 | $2K | |
| 86694 | <1% | 70 | $2K | |
| 84153 | <1% | 50 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 40 | $2K |
| 83013 | <1% | 13 | $2K | |
| 84480 | <1% | 59 | $2K | |
| 82962 | <1% | 266 | $2K | |
| 86704 | <1% | 64 | $2K | |
| 86617 | <1% | 48 | $2K | |
| 86762 | <1% | 41 | $1K | |
| 84270 | <1% | 28 | $1K | |
| 83721 | <1% | 87 | $1K | |
| 86787 | <1% | 41 | $1K | |
| 86765 | <1% | 40 | $1K | |
| 84481 | <1% | 87 | $1K | |
| 86664 | <1% | 31 | $993.86 | |
| 82040 | <1% | 117 | $858.80 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 16 | $852.32 |
| 86663 | <1% | 31 | $852.19 | |
| 80358 | <1% | 81 | $847.08 | |
| 86735 | <1% | 27 | $791.37 | |
| 80353 | <1% | 77 | $727.33 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 12 | $673.80 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 40 | $483.80 |
| 86677 | <1% | 13 | $395.33 | |
| 84702 | <1% | 12 | $378.48 | |
| 86225 | <1% | 12 | $345.48 | |
| 83655 | <1% | 32 | $334.26 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $285.48 |
| 84484 | <1% | 17 | $248.78 | |
| 90785 | <1% | 38 | $243.97 | |
| 86200 | <1% | 26 | $208.65 | |
| 85730 | <1% | 13 | $163.67 | |
| 90686 | <1% | 287 | $55.83 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFOGARTY, JOHN (PRESIDENT)
Parent organizationST JOSEPH HEALTH SERVICES OF RI
| Provider | Location | Paid |
|---|---|---|
| Irvine Unified School District | Irvine, CA | $4.94M |
| Brea-Olinda School District | Brea, CA | $702K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.